S.Amdt. 3102Senate111th Congress (2009-2011)2nd degree
S.Amdt. 3102
Sponsored by
Sen. Richard J. Durbin (D-IL)
Submitted December 9, 2009
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
December 9, 2009
Text
Submitted
SA 3102. Mr. DURBIN (for himself and Mr. Casey) submitted an amendment intended to be proposed to amendment SA 2786 proposed by Mr. Reid (for himself, Mr. Baucus, Mr. Dodd, and Mr. Harkin) to the bill H.R. 3590, to amend the Internal Revenue Code of 1986 to modify the first-time homebuyers credit in the case of members of the Armed Forces and certain other Federal employees, and for other purposes; which was ordered to lie on the table; as follows: On page 816, after line 20, insert the following: SEC. 3115. EXTENDED MONTHS OF COVERAGE OF IMMUNOSUPPRESSIVE DRUGS FOR KIDNEY TRANSPLANT PATIENTS AND OTHER RENAL DIALYSIS PROVISIONS. (a) Provision of Appropriate Coverage of Immunosuppressive Drugs Under the Medicare Program for Kidney Transplant Recipients.-- (1) Continued entitlement to immunosuppressive drugs.-- (A) Kidney transplant recipients.--Section 226A(b)(2) of the Social Security Act (42 U.S.C. 426-1(b)(2)) is amended by inserting ``(except for coverage of immunosuppressive drugs under section 1861(s)(2)(J))'' before ``, with the thirty- sixth month''. (B) Application.--Section 1836 of such Act (42 U.S.C. 1395o) is amended-- (i) by striking ``Every individual who'' and inserting ``(a) In General.--Every individual who''; and (ii) by adding at the end the following new subsection: ``(b) Special Rules Applicable to Individuals Only Eligible for Coverage of Immunosuppressive Drugs.-- ``(1) In general.--In the case of an individual whose eligibility for benefits under this title has ended on or after January 1, 2012, except for the coverage of immunosuppressive drugs by reason of section 226A(b)(2), the following rules shall apply: ``(A) The individual shall be deemed to be enrolled under this part for purposes of receiving coverage of such drugs. ``(B) The individual shall be responsible for providing for payment of the portion of the [[Page S12828]] premium under section 1839 which is not covered under the Medicare savings program (as defined in section 1144(c)(7)) in order to receive such coverage. ``(C) The provision of such drugs shall be subject to the application of-- ``(i) the deductible under section 1833(b); and ``(ii) the coinsurance amount applicable for such drugs (as determined under this part). ``(D) If the individual is an inpatient of a hospital or other entity, the individual is entitled to receive coverage of such drugs under this part. ``(2) Establishment of procedures in order to implement coverage.--The Secretary shall establish procedures for-- ``(A) identifying individuals that are entitled to coverage of immunosuppressive drugs by reason of section 226A(b)(2); and ``(B) distinguishing such individuals from individuals that are enrolled under this part for the complete package of benefits under this part.''. (C) Technical amendment to correct duplicate subsection designation.--Subsection (c) of section 226A of such Act (42 U.S.C. 426-1), as added by section 201(a)(3)(D)(ii) of the Social Security Independence and Program Improvements Act of 1994 (Public Law 103-296; 108 Stat. 1497), is redesignated as subsection (d). (2) Extension of secondary payer requirements for esrd beneficiaries.--Section 1862(b)(1)(C) of the Social Security Act (42 U.S.C. 1395y(b)(1)(C)) is amended by adding at the end the following new sentence: ``With regard to immunosuppressive drugs furnished on or after the date of the enactment of the Patient Protection and Affordable Care Act, this subparagraph shall be applied without regard to any time limitation.''. (b) Medicare Coverage for ESRD Patients.--Section 1881 of the Social Security Act is amended-- (1) in subsection (b)(14)(B)(iii), by inserting ``, including oral drugs that are not the oral equivalent of an intravenous drug (such as oral phosphate binders and calcimimetics),'' after ``other drugs and biologicals''; (2) in subsection (b)(14)(E)(ii)-- (A) in the first sentence-- (i) by striking ``a one-time election to be excluded from the phase-in'' and inserting ``an election, with respect to 2011, 2012, or 2013, to be excluded from the phase-in (or the remainder of the phase-in)''; and (ii) by adding before the period at the end the following: ``for such year and for each subsequent year during the phase-in described in clause (i)''; and (B) in the second sentence-- (i) by striking ``January 1, 2011'' and inserting ``the first date of such year''; and (ii) by inserting ``and at a time'' after ``form and manner''; and (3) in subsection (h)(4)(E), by striking ``lesser'' and inserting ``greater''. ______